{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:06Z","timestamp":1786119486115,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/mph.0b013e3181d0800f","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T02:41:53Z","timestamp":1269312113000},"page":"336-337","source":"Crossref","is-referenced-by-count":2,"title":["Regarding \u201cIntrathecal Vincristine: 3 Fatal Cases and a Review of the Literature\u201d"],"prefix":"10.1097","volume":"32","author":[{"given":"Andrew W.","family":"Walter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210227","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/MPH.0b013e3181b83fba","article-title":"Intrathecal vincristine: 3 fatal cases and a review of the literature","volume":"31","author":"Hennipman","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"R2-22-20210227","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mpo.2950240114","article-title":"Neurologic consequences of accidental intrathecal vincristine: a case report","volume":"24","author":"Zaragoza","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"R3-22-20210227","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/08880019109033445","article-title":"Vincristine overdose: experience with 3 patients","volume":"8","author":"Kosmidis","year":"1991","journal-title":"Pediatr Hematol Oncol"},{"key":"R4-22-20210227","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0002-9343(88)90306-3","article-title":"Amelioration of vincristine neurotoxicity by glutamic acid","volume":"84","author":"Jackson","year":"1988","journal-title":"Am J Med"},{"key":"R5-22-20210227","first-page":"1016","article-title":"Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine","volume":"20","author":"Johnson","year":"1960","journal-title":"Cancer Res"},{"key":"R6-22-20210227","first-page":"1390","article-title":"The vinca alkaloids: a new class of oncolytic agents","volume":"23","author":"Johnson","year":"1963","journal-title":"Cancer Res"},{"key":"R7-22-20210227","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00005072-196810000-00008","article-title":"Neuronal changes induced by intrathecal vincristine sulfate","volume":"27","author":"Schochet","year":"1968","journal-title":"J Neuropathol Exp Neurol"},{"key":"R8-22-20210227","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/mpo.2950050113","article-title":"Accidental intrathecal administration of vincristine","volume":"5","author":"Shepherd","year":"1978","journal-title":"Med Pediatr Oncol"},{"key":"R9-22-20210227","first-page":"313","article-title":"Pyridoxine modification of vincristine toxicity [abstract]","volume":"25","author":"Jackson","year":"1984","journal-title":"Proc Am Assoc Cancer Res"},{"key":"R10-22-20210227","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/08880010701451327","article-title":"Pyridoxine and pyridostigmine treatment in vincristine-induced neuropathy","volume":"24","author":"Ozyurek","year":"2007","journal-title":"Pediatr Hematol Oncol"},{"key":"R11-22-20210227","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02158000","article-title":"Clinical trial of pyridoxine to reduce vincristine neurotoxicity","volume":"4","author":"Jackson","year":"1986","journal-title":"J Neurooncol"},{"key":"R12-22-20210227","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00314787","article-title":"Intrathecal vincristine: a fatal chemotherapeutic error with devastating central nervous system effects","volume":"238","author":"Bain","year":"1991","journal-title":"J Neurol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3181d0800f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:16:28Z","timestamp":1786040188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-201005000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181d0800f","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}